Verily (company)

Verily (company)
Name	Verily Life Sciences
Type	Subsidiary
Industry	Biotechnology
Founded	2015
Founder	Larry Page, Sergey Brin, Glenn Murphy
Headquarters	South San Francisco, California
Area served	Worldwide
Parent	Alphabet Inc.

Verily (company) is a biomedical research and life sciences company focused on clinical research, medical devices, and data-driven healthcare solutions. It operates as a subsidiary of Alphabet Inc. and combines expertise from technology firms, academic institutions, and healthcare organizations to pursue population health, translational research, and device development. Verily's work spans collaborations with pharmaceutical companies, hospitals, and government agencies.

History

Verily emerged in the mid-2010s from initiatives within Google and Alphabet Inc. that targeted healthcare innovation, building on antecedents such as Google X and projects led by engineers and clinicians formerly associated with Stanford University, Massachusetts Institute of Technology, and Johns Hopkins University. Early milestones included assembling teams with backgrounds from Genentech, Pfizer, Novartis, and Roche, and launching programs related to wearable sensors, clinical trial platforms, and population studies. Verily announced major partnerships and pilot programs with institutions like Mayo Clinic, Cleveland Clinic, and Mount Sinai Health System, while engaging regulators such as the U.S. Food and Drug Administration and agencies including the National Institutes of Health. Over time its trajectory intersected with large-scale initiatives in precision medicine, echoing efforts by National Health Service (England), All of Us Research Program, and consortia involving Cambridge University and Imperial College London.

Business and Operations

Verily's operational model blends in-house engineering, clinical research, and commercialization through collaborations with biopharmaceutical corporations like Sanofi, GlaxoSmithKline, AstraZeneca, and Bayer. It organizes teams focused on device development, software platforms, and data analytics, and has engaged contract research organizations such as IQVIA and PRA Health Sciences for trial execution. Facilities and manufacturing partnerships have involved companies like Flex Ltd. and Medtronic for scaling hardware. Verily's customers and partners encompass academic medical centers including University of California, San Francisco, Harvard Medical School, and Yale School of Medicine, alongside public health agencies like Centers for Disease Control and Prevention and municipal health departments. Revenue streams derive from collaborations, product licensing, and service agreements with payers and providers including Kaiser Permanente and UnitedHealth Group affiliates.

Products and Technologies

Verily developed a portfolio of platforms and devices spanning wearable sensors, imaging tools, and clinical research software. Notable projects included a health-tracking wristband and a continuous glucose monitoring collaboration referenced alongside devices from Dexcom, Abbott Laboratories, and Roche Diabetes Care. Verily's clinical research platform was positioned to integrate with electronic health record systems from Epic Systems and Cerner Corporation and to support decentralized trials in partnership with companies like Pfizer and Johnson & Johnson. Other technologies involved lab automation and single-cell analysis concepts paralleling work at 10x Genomics and Illumina. Verily pursued digital biomarkers, machine learning models comparable to efforts by DeepMind and IBM Watson Health, and imaging analytics akin to research at GE Healthcare and Siemens Healthineers.

Research and Partnerships

Verily's research collaborations spanned academia, industry, and public agencies. It partnered with Sanofi on clinical programs, with GlaxoSmithKline on disease surveillance, and with Scripps Research and Stanford Medicine on translational projects. Large population studies involved coordination with the All of Us Research Program and regional cohorts similar to initiatives by UK Biobank and Framingham Heart Study investigators. Verily co-developed trials and registries with pharmaceutical firms such as AstraZeneca and Novartis, and engaged consortia including research centers funded by Wellcome Trust and Howard Hughes Medical Institute. Methodological collaborations drew on statistical and computational research at institutions like Princeton University, Columbia University, and University of Washington.

Legal and Regulatory Issues

Verily's activities intersected with regulatory frameworks administered by the U.S. Food and Drug Administration, European Medicines Agency, and national data protection authorities including the Information Commissioner's Office (United Kingdom). Legal issues included data privacy scrutiny, intellectual property disputes, and compliance with medical device regulations similar to precedents involving Medtronic and Boston Scientific. Verily navigated contract negotiations and antitrust considerations in collaborations with large pharmaceutical partners such as Pfizer and Sanofi, while responding to inquiries from legislators and oversight bodies analogous to actions by committees in the United States Congress and European Parliament. Litigation and regulatory filings referenced standards established in cases involving technology and health companies like Facebook and Apple.

Corporate Governance and Funding

Verily operates under the corporate structure of Alphabet Inc. with oversight from a board and executive leadership drawn from technology and healthcare sectors, echoing governance patterns at Google LLC and Waymo. Funding and financial arrangements include internal capital allocations from Alphabet Inc., strategic investment rounds with partners such as Sequoia Capital-type investors, and joint-venture financing with firms like Sanofi and GlaxoSmithKline. Executive leadership has included figures with prior roles at Google, Genentech, and McKinsey & Company, while independent directors and advisors have ties to Harvard Business School, Wharton School, and international healthcare organizations such as the World Health Organization.

Category:Biotechnology companies